Starton Therapeutics
Shannon Wisniewski has been working in the pharmaceutical industry since 2008. Shannon began their career at Sanofi Pasteur as a Research to Launch Technician in 2008. In 2009, they moved to ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, as a Research Associate. In 2014, they became a Global Launch Project Manager at Eli Lilly and Company. In 2018, they took on the role of Project Manager at Clinical Genomics. Currently, they are the Director of Program Management at Starton Therapeutics.
Shannon Wisniewski graduated from York College of Pennsylvania with a Bachelor of Science degree.
This person is not in any offices
Starton Therapeutics
Starton Therapeutics is a clinical-stage biotechnology company that is transforming standard-of-care therapies with proprietary transdermal technology, so people with cancer can receive continuous treatment to live better, longer.